- Home
- ERJ vs ROIV Comparison
ERJ vs ROIV Comparison
Compare ERJ & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERJ
- ROIV
- Stock Information
- Founded
- ERJ 1969
- ROIV 2014
- Country
- ERJ Brazil
- ROIV United Kingdom
- Employees
- ERJ N/A
- ROIV N/A
- Industry
- ERJ Aerospace
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- ERJ Industrials
- ROIV Health Care
- Exchange
- ERJ Nasdaq
- ROIV Nasdaq
- Market Cap
- ERJ 8.6B
- ROIV 8.4B
- IPO Year
- ERJ 2000
- ROIV N/A
- Fundamental
- Price
- ERJ $47.66
- ROIV $11.02
- Analyst Decision
- ERJ Buy
- ROIV Buy
- Analyst Count
- ERJ 5
- ROIV 4
- Target Price
- ERJ $48.75
- ROIV $17.50
- AVG Volume (30 Days)
- ERJ 1.1M
- ROIV 5.9M
- Earning Date
- ERJ 05-06-2025
- ROIV 05-29-2025
- Dividend Yield
- ERJ 0.10%
- ROIV N/A
- EPS Growth
- ERJ 70.71
- ROIV N/A
- EPS
- ERJ 0.52
- ROIV N/A
- Revenue
- ERJ $6,519,769,233.00
- ROIV $122,585,000.00
- Revenue This Year
- ERJ N/A
- ROIV N/A
- Revenue Next Year
- ERJ $13.68
- ROIV N/A
- P/E Ratio
- ERJ $92.53
- ROIV N/A
- Revenue Growth
- ERJ 39.31
- ROIV 140.04
- 52 Week Low
- ERJ $25.24
- ROIV $8.73
- 52 Week High
- ERJ $56.61
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- ERJ 55.91
- ROIV 52.88
- Support Level
- ERJ $48.37
- ROIV $10.58
- Resistance Level
- ERJ $50.14
- ROIV $11.06
- Average True Range (ATR)
- ERJ 1.42
- ROIV 0.31
- MACD
- ERJ 0.14
- ROIV -0.04
- Stochastic Oscillator
- ERJ 71.13
- ROIV 32.03
About ERJ Embraer S.A.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.